CH361286A - Process for the preparation of new benzimidazoles - Google Patents
Process for the preparation of new benzimidazolesInfo
- Publication number
- CH361286A CH361286A CH361286DA CH361286A CH 361286 A CH361286 A CH 361286A CH 361286D A CH361286D A CH 361286DA CH 361286 A CH361286 A CH 361286A
- Authority
- CH
- Switzerland
- Prior art keywords
- halogen
- benzyl
- acid
- formula
- diethylamino
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- 150000001556 benzimidazoles Chemical class 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title description 3
- 150000003839 salts Chemical class 0.000 claims description 9
- -1 alkylene radical Chemical class 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 229910052736 halogen Chemical group 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- 125000001302 tertiary amino group Chemical group 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 150000003254 radicals Chemical class 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 150000007514 bases Chemical class 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- FCOUPXKPTIHONH-UHFFFAOYSA-N 6-chloro-2-[(4-methoxyphenyl)methyl]-1h-benzimidazole Chemical compound C1=CC(OC)=CC=C1CC1=NC2=CC=C(Cl)C=C2N1 FCOUPXKPTIHONH-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LFDGRWDETVOGDT-UHFFFAOYSA-N 1h-pyrrole;hydrochloride Chemical compound Cl.C=1C=CNC=1 LFDGRWDETVOGDT-UHFFFAOYSA-N 0.000 description 1
- PACGLQCRGWFBJH-UHFFFAOYSA-N 2-(4-methoxyphenyl)acetonitrile Chemical compound COC1=CC=C(CC#N)C=C1 PACGLQCRGWFBJH-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- PLOSSHSFATUNTF-UHFFFAOYSA-N [K]C1=CC=CC=C1 Chemical compound [K]C1=CC=CC=C1 PLOSSHSFATUNTF-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- ZRLVQFQTCMUIRM-UHFFFAOYSA-N potassium;2-methylbutan-2-olate Chemical compound [K+].CCC(C)(C)[O-] ZRLVQFQTCMUIRM-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 125000005853 β-dimethylaminoethyl group Chemical group 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung neuer Benzimidazole Gegenstand der Erfindung ist ein Verfahren zur Herstellung von 1- (tert. - Amino - niederalkyl) - 2 - (p-alkoxy-benzyl)-benzimidazolen der Formel
EMI0001.0007
worin A einen niederen Alkylenrest, R eine tertiäre Aminogruppe und alkyl eine Alkylgruppe bedeuten, und worin einer der Reste R1 und R, für Wasserstoff oder Halogen und der andere für Halogen steht.
Die tertiäre Aminogruppe ist beispielsweise eine gege benenfalls durch ein Heteroatom unterbrochene niedere Alkyleniminogruppe, wie eine Piperidino-, Pyrrolidino- oder Morpholinogruppe, besonders aber eine Di-niederalkyl-aminogruppe, vor allem die Di- äthylaminogruppe.
Die neuen Verbindungen sind wirksam als Anal getika und Muskelrelaxantia und können dement sprechend als Arzneimittel Verwendung finden. Von besonderem Interesse wegen ihrer therapeutischen Eigenschaften sind die Verbindungen der Formel
EMI0001.0025
worin alkyl für einen Niederalkylrest, wie Methyl, Propyl, in erster Linie Äthyl, steht, und R1 undioder R2 Chlor bedeuten, wie 1-(ss-Diäthylamino-äthyl)-2- (p-äthoxy-benzyl)-5-chlor-benzimidazol,
1-(ss Diäthyl- amino-äthyl)-2 (p-methoxy-benzyl)-5-chlor-benzimid- azol und ihre Salze.
Das erfindungsgemässe Verfahren ist dadurch ge kennzeichnet, dass man ein 2-(p-Alkoxy-benzyl)-5- und/oder -6-halogen-benzimidazol mit einem reak tionsfähigen Ester eines Alkohols der Formel HO-A-R umsetzt.
Reaktionsfähige Ester sind insbesondere solche starker anorganischer oder organischer Säuren, wie der Halogenwasserstoffsäuren, oder organischer Sulfonsäuren, wie p-Toluol-sulfonsäure. Die Um setzung wird vorzugsweise vorgenommen in Gegen wart von Kondensationsmitteln, insbesondere sol cher, die mit den 2-(p-Alkoxy-benzyl)-benzimidazolen Metallsalze zu bilden vermögen, wie Alkali- und Erdalkalimetalle, beispielsweise Natrium, Lithium und Calcium, ihre Amide, Hydride, Kohlenwasser stoffverbindungen,
Alkoholate, Oxyde und Hy- droxyde, z. B. Natriumamid, Natriumhydrid, Butyl- lithium, Phenylkalium, Phenyllithium, Kalium-tert.- butylat, Kalium-tert.-amylat, Natriumäthylat, Na triumoxyd und Natriumhydroxyd, oder unter Ver wendung der vorgebildeten Metallsalze der Benz imidazole.
Die Umsetzungen können in An- oder Abwesen heit von Verdünnungs- undloder Kondensationsmit- teln, wenn nötig, bei erhöhter Temperatur, im offenen oder im geschlossenen Gefäss unter Druck ausgeführt werden.
Je nach der Arbeitsweise erhält man die neuen Verbindungen in Form der freien Basen oder ihrer Salze. Aus den Salzen können in an sich bekannter Weise die freien Basen gewonnen werden. Von letz teren lassen sich durch Umsetzung mit Säuren, die zur Bildung therapeutisch verwendbarer Salze ge eignet sind, Salze gewinnen, wie z.
B. von Halogen wasserstoffsäuren, Schwefelsäure, Salpetersäure, Phosphorsäure, Rhodanwasserstoffsäure, Essigsäure, Propionsäure, Oxalsäure, Malonsäure, Bernstein säure, Apfelsäure, Methansulfonsäure, Äthansulfon- säure, Oxyäthansulfonsäure, Benzol- oder Toluol- sulfonsäure oder von therapeutisch wirksamen Säuren.
Die Ausgangsstoffe sind bekannt oder können nach an sich bekannten Methoden gewonnen werden. Die neuen Verbindungen können als Arznei mittel, z. B. in Form pharmazeutischer Präparate, Verwendung finden, welche sie oder ihre Salze in Mischung mit einem für die enterale, parenterale oder topicale Applikation geeigneten, pharmazeuti schen, organischen oder anorganischen, festen oder flüssigen Trägermaterial enthalten.
Im folgenden Beispiel sind die Temperaturen in Celsiusgraden angegeben.
<I>Beispiel</I> 2,7 g 2-(p-Methoxy-benzyl)-5-chlor-benzimidazol werden in 100 cm3 absolutem Dioxan gelöst, 0,4 g Natriumamid werden unter Rühren zugefügt. Die Re aktionsmischung wird auf 70 erwärmt.
Bei dieser Temperatur werden 1,4 g ss-Diäthylamino-äthyl- chlorid, gelöst in 10 cm3 Dioxan, während 1 Stunde langsam zugetropft. Unter Rühren wird die Reak tionsmischung 4 Stunden bei 70 gehalten, dann mit Norit (Markenprodukt) versetzt, filtriert, einge dampft und in 100 cm3 Äther aufgenommen.
Die ätherische Lösung wird dreimal mit 20 cm3 1n Salz säure ausgeschüttelt, der Salzsäureauszug mit Na tronIauge alkalisch gestellt und die freigesetzte Base in Äther aufgenommen, getrocknet und vom Lö sungsmittel befreit. Durch Lösen in Alkohol und Zugabe von einem Äquivalent alkoholischer Salz säure wird die Base in ihr Hydrochlorid übergeführt. Das so erhaltene 1-(ss-Diäthylamino-äthyl)-2-(p- methoxy-benzyl)-5-chlor-benzimid'azol-hydrochlorid schmilzt bei 183-184 .
Das als Ausgangsmaterial verwendete 2-(p-Meth- oxy-benzyl)-5-chlor-benzimidazol kann wie folgt her gestellt werden: 11,8 g p-Methoxy-benzylcyanid werden in einer Mischung von 80 cm3 Chloroform und 4,64 cm3 Äthanol gelöst.
Die Mischung wird bei 0 mit trockenem Salzsäuregas gesättigt und 12 Stunden bei Zimmertemperatur stehengelassen. 10 g 2 Amino- 5-chlor-anüin, in 100 cm3 Chloroform gelöst, wer den nun zu der oben genannten Reaktionsmischung zugefügt und das ganze 12 Stunden am Rückfluss gehalten. Zu der abgekühlten Reaktionsmischung werden 200 eins Wasser zugefügt und so viel wässriges Ammoniak, dass nach dem Durchschütteln der zwei Phasen die wässrige Schicht deutlich alka lisch reagiert.
Die Chloroformschicht wird mit Ma gnesiumsulfat getrocknet, eingedampft und der Rückstand aus Chloroform-Ligroin kristallisiert. Das erhaltene 2-(p-Methoxy-benzyl)-5-chlor-benzimidazol schmilzt bei 169 .
In analoger Weise können die folgenden Verbin dungen hergestellt werden: 1- (ss-Diäthylamino-äthyl)-2-(p-äthoxy-benzyl)-5- chlor-benzimidazol, F. des Hydrochlorids 205-207 ; 1- (ss - Diäthylamino-äthyl)-2-(p-methoxy-benzyl)- 5,6-dichlor-benzimidazol, F. des Hydrochlorids 220 ; 1-(ss Diäthylamino-äthyl)-2-(p-äthoxy-benzyl)-5,6- dichlor-benzimidazol, F. des Hydrochlorids 115 ; 1-(ss-Dimethylamino-äthyl)-2-(p-äthoxy-benzyl)- 5,6-dichlor-benzimidazol, F. 86-87 ;
F. des Hydro- chlorids 120-130 .
Process for the preparation of new benzimidazoles The invention relates to a process for the preparation of 1- (tert-amino-lower-alkyl) -2- (p-alkoxy-benzyl) -benzimidazoles of the formula
EMI0001.0007
in which A is a lower alkylene radical, R is a tertiary amino group and alkyl is an alkyl group, and in which one of the radicals R1 and R is hydrogen or halogen and the other is halogen.
The tertiary amino group is, for example, a lower alkyleneimino group optionally interrupted by a heteroatom, such as a piperidino, pyrrolidino or morpholino group, but especially a di-lower alkylamino group, especially the diethylamino group.
The new compounds are effective as analgesics and muscle relaxants and can accordingly be used as drugs. The compounds of the formula are of particular interest because of their therapeutic properties
EMI0001.0025
wherein alkyl is a lower alkyl radical, such as methyl, propyl, primarily ethyl, and R1 undi or R2 are chlorine, such as 1- (ss-diethylamino-ethyl) -2- (p-ethoxy-benzyl) -5-chloro- benzimidazole,
1- (ss diethylamino-ethyl) -2 (p-methoxy-benzyl) -5-chloro-benzimidazole and their salts.
The process according to the invention is characterized in that a 2- (p-alkoxy-benzyl) -5- and / or -6-halogen-benzimidazole is reacted with a reactive ester of an alcohol of the formula HO-A-R.
Reactive esters are in particular those strong inorganic or organic acids, such as hydrohalic acids, or organic sulfonic acids, such as p-toluenesulfonic acid. The implementation is preferably carried out in the presence of condensation agents, especially those capable of forming metal salts with the 2- (p-alkoxy-benzyl) -benzimidazoles, such as alkali and alkaline earth metals, for example sodium, lithium and calcium, their amides , Hydrides, hydrocarbon compounds,
Alcoholates, oxides and hydroxides, e.g. B. Sodium amide, sodium hydride, butyllithium, phenylpotassium, phenyllithium, potassium tert-butoxide, potassium tert-amylate, sodium ethylate, sodium oxide and sodium hydroxide, or using the preformed metal salts of benzimidazoles.
The reactions can be carried out in the presence or absence of diluents and / or condensation agents, if necessary, at elevated temperature, in an open or in a closed vessel under pressure.
Depending on the procedure, the new compounds are obtained in the form of the free bases or their salts. The free bases can be obtained from the salts in a manner known per se. Of the latter can be obtained by reacting with acids that are ge for the formation of therapeutically useful salts, salts such.
B. of hydrohalic acids, sulfuric acid, nitric acid, phosphoric acid, hydrofluoric acid, acetic acid, propionic acid, oxalic acid, malonic acid, succinic acid, malic acid, methanesulfonic acid, ethanesulfonic acid, oxyethanesulfonic acid, benzene or toluene sulfonic acid or therapeutically active acids.
The starting materials are known or can be obtained by methods known per se. The new compounds can be used as medicaments, e.g. B. in the form of pharmaceutical preparations, find use which they or their salts in a mixture with a suitable for enteral, parenteral or topical application, pharmaceutical rule, organic or inorganic, solid or liquid carrier material.
In the following example the temperatures are given in degrees Celsius.
<I> Example </I> 2.7 g of 2- (p-methoxy-benzyl) -5-chlorobenzimidazole are dissolved in 100 cm3 of absolute dioxane, 0.4 g of sodium amide are added with stirring. The reaction mixture is heated to 70.
At this temperature, 1.4 g of β-diethylamino-ethyl chloride, dissolved in 10 cm3 of dioxane, are slowly added dropwise over the course of 1 hour. The reaction mixture is kept at 70 for 4 hours while stirring, then Norit (branded product) is added, the mixture is filtered, evaporated and taken up in 100 cm3 of ether.
The ethereal solution is extracted three times with 20 cm3 of 1N hydrochloric acid, the hydrochloric acid extract is made alkaline with sodium hydroxide solution and the released base is taken up in ether, dried and freed from the solvent. The base is converted into its hydrochloride by dissolving in alcohol and adding one equivalent of alcoholic hydrochloric acid. The 1- (ß-diethylamino-ethyl) -2- (p-methoxy-benzyl) -5-chlorobenzimid'azole hydrochloride thus obtained melts at 183-184.
The 2- (p-methoxy-benzyl) -5-chlorobenzimidazole used as starting material can be prepared as follows: 11.8 g of p-methoxy-benzyl cyanide are added in a mixture of 80 cm 3 of chloroform and 4.64 cm 3 Dissolved ethanol.
The mixture is saturated with dry hydrochloric acid gas at 0 and left to stand for 12 hours at room temperature. 10 g of 2 amino-5-chloroanal, dissolved in 100 cm3 of chloroform, are now added to the above-mentioned reaction mixture and refluxed for 12 hours. 200 liters of water are added to the cooled reaction mixture, along with enough aqueous ammonia that, after the two phases have been shaken through, the aqueous layer reacts clearly alkaline.
The chloroform layer is dried with magnesium sulphate, evaporated and the residue is crystallized from chloroform-ligroin. The 2- (p-methoxy-benzyl) -5-chlorobenzimidazole obtained melts at 169.
The following compounds can be prepared in an analogous manner: 1- (ss-diethylamino-ethyl) -2- (p-ethoxy-benzyl) -5-chloro-benzimidazole, F. des hydrochloride 205-207; 1- (ss-diethylamino-ethyl) -2- (p-methoxy-benzyl) -5,6-dichlorobenzimidazole, F. des Hydrochlorids 220; 1- (ss diethylamino-ethyl) -2- (p-ethoxy-benzyl) -5,6-dichlorobenzimidazole, F. des hydrochloride 115; 1- (ss-dimethylamino-ethyl) -2- (p-ethoxy-benzyl) -5,6-dichloro-benzimidazole, m.p. 86-87;
F. of the hydrochloride 120-130.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH361286T | 1957-09-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH361286A true CH361286A (en) | 1962-04-15 |
Family
ID=4512915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH361286D CH361286A (en) | 1957-09-27 | 1957-09-27 | Process for the preparation of new benzimidazoles |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH361286A (en) |
-
1957
- 1957-09-27 CH CH361286D patent/CH361286A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2205815A1 (en) | N-(oxazolin-2-yl)-piperazine - with antitussive activity | |
| DE3045688A1 (en) | NEW 8-ARYLALKYL-3-PHENYL-3-NORTROPANOLE, THE ACID ADDITION SALTS THEREOF, THE MEDICINAL PRODUCTS CONTAINING THE SAME AND METHOD FOR THE PRODUCTION THEREOF | |
| DE2628570A1 (en) | 10-SQUARE BRACKET ON OMEGA (BENZOYLPIPERIDINYL) -ALKYL SQUARE BRACKET FOR PHENOTHIAZINE AND THE PROCESS FOR THEIR PRODUCTION | |
| CH361286A (en) | Process for the preparation of new benzimidazoles | |
| AT205971B (en) | Process for the preparation of new benzimidazoles | |
| AT205970B (en) | Process for the preparation of new benzimidazoles | |
| AT205972B (en) | Process for the preparation of new benzimidazoles | |
| CH361575A (en) | Process for the preparation of new benzimidazoles | |
| AT210417B (en) | Process for the preparation of new benzimidazoles | |
| AT212310B (en) | Process for the preparation of new benzimidazoles | |
| AT207379B (en) | Process for the preparation of new benzimidazoles | |
| AT208852B (en) | Process for the preparation of new benzimidazoles | |
| CH361285A (en) | Process for the preparation of new benzimidazoles | |
| AT205968B (en) | Process for the preparation of new benzimidazoles | |
| AT226690B (en) | Process for the preparation of new 1-R-2,5-bis-halomethyl-pyrrolidines and of acid addition salts and quaternary ammonium compounds thereof | |
| CH363983A (en) | Process for the preparation of new benzimidazoles | |
| AT209338B (en) | Process for the preparation of new benzimidazoles | |
| AT247318B (en) | Process for the production of new imidazoles | |
| AT223331B (en) | Process for the production of new tropane derivatives | |
| AT264526B (en) | Process for the preparation of new tetrahydroisoquinoline derivatives and acid addition salts thereof | |
| AT270659B (en) | Process for the preparation of new halogen-substituted tetrahydroquinazolines and their acid addition salts | |
| CH363984A (en) | Process for the preparation of new benzimidazoles | |
| AT222117B (en) | Process for the production of new azabenz-imidazoles | |
| CH649540A5 (en) | 1,2,4-OXADIAZINE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE OXADIAZINE DERIVATIVES. | |
| AT221089B (en) | Process for the production of new azabenz-imidazoles |